Author: Ken Dropiewski

Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial

– A new, first-of-its-kind study known as TAP-CHF leverages expertise across Abbott’s cardiovascular portfolio to optimize treatment for patients suffering from both AFib and heart failure – The trial will utilize Abbott technology including cardiac ablation and sensors to monitor for both pulmonary artery pressure and abnormal heartbeats – Historically, […]

Hicuity Health Honored with MedTech Breakthrough Award for Second Consecutive Year

Company Earns “Best Hospital Technology Implementation” Recognition for System-Wide Expansion of Rhythm CI Remote Telemetry ST. LOUIS, May 6, 2021 /PRNewswire/ — Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced that the company has been recognized by MedTech Breakthrough for the second consecutive year. The company earned recognition for the “Best Hospital […]

Christopher Graybill Joins ARCA as Vice President, Clinical Development

WESTMINSTER, Colo., May 05, 2021 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Christopher Graybill, Ph.D., has joined ARCA as Vice President, Clinical Development. Dr. Michael Bristow, ARCA’s President and Chief Executive Officer, […]

Eko Recognized for Artificial Intelligence Innovation in Healthcare with 2021 MedTech Breakthrough Awards

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies OAKLAND, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced that it has been selected as the winner of the “Best Use of Artificial Intelligence in Healthcare” award in the fifth annual MedTech […]

Daxor Corporation Receives National Institutes of Health (NIH) Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs

NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume Analysis guided management of acute decompensated heart failure (ADHF) utilizing […]

Altavant Sciences Advances Rodatristat Ethyl into Phase 2b Clinical Trial for Pulmonary Arterial Hypertension

Cary, N.C. and Basel, Switzerland, May 06, 2021 (GLOBE NEWSWIRE) — Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, announced today that the company has initiated its ELEVATE 2 Study, a Phase 2b clinical trial of its lead product candidate, rodatristat ethyl (“rodatristat”), for the […]

Madrigal Pharmaceuticals Reports 2021 First Quarter Financial Results and Highlights

WEST CONSHOHOCKEN, Pa., May 06, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its first quarter 2021 financial results and highlights. “We expect several important events for Madrigal to occur in 2021,” stated Paul Friedman, M.D., Chief Executive Officer of Madrigal. “These include completing enrolling a sufficient number […]

Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock

SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the third quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The third quarterly cash dividend equals $0.593750 per share, at […]